Microalbuminuria

Search with Google Search with Bing
Information
Disease name
Microalbuminuria
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02122731 Completed Phase 4 Amiloride for Resistant Hypertension November 2010 August 2012
NCT00907374 Completed N/A Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria July 2005 April 2009
NCT00550095 Completed Phase 4 To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus June 2007 November 2009
NCT00317915 Completed Phase 3 Irbesartan in Type 2 Diabetes
NCT00572403 Completed Risk Factors Contributing to the Development of Microalbuminuria December 2007 April 2008
NCT02729441 Completed Phase 3 Perindopril vs Ramipril for Persistence in MAU Reduction Study April 2010 December 2012
NCT00320879 Completed Phase 4 Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria September 2003 November 2004
NCT03073018 Completed Phase 3 Prevention of Renal and Vascular Endstage Disease Intervention Trial April 1998 November 2003
NCT03089333 Completed Phase 4 Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects July 2016 December 2017
NCT03238547 Completed Screening of Microalbuminuria Using a Semi-quantitative UACR Test August 1, 2017 December 31, 2019
NCT03470454 Completed Contrast Nephropathy in Type 2 Diabetes July 1, 2018 November 30, 2018
NCT01552954 Completed Phase 4 Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan February 2012 October 2013
NCT03889236 Completed N/A Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy. May 3, 2018 September 9, 2020
NCT00484068 Completed N/A Chicken-Diet vs. Enalapril to Reduce Albuminuria January 2003 June 2006
NCT00961207 Terminated Phase 4 Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients August 2009 September 2012
NCT00458081 Terminated Phase 3 Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors March 2007 January 2009
NCT02048904 Terminated Phase 4 Use of Sitagliptin to Decrease Microalbuminuria January 2014 June 2016
NCT02068833 Unknown status Resolution of Microalbuminuria and Dysmetabolism Following Bariatric Surgery: Prospective Study June 2013 December 2016
NCT00427271 Unknown status Phase 4 Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients March 2003 January 2007
NCT01092169 Unknown status Prevalence Of Microalbuminuria Among Children Suffering From Sickle Cell Nephropathy and Sickle Cell/Beta-Thalassemia
NCT01230034 Unknown status Phase 3 Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria October 2010 July 2011
NCT01891292 Unknown status N/A Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle Nephropathy July 2013 September 2015
NCT01907958 Unknown status Management of Albuminuria in Hypertensive Diabetics April 2013 June 2014
NCT02314533 Unknown status Phase 4 Evaluate the Efficacy of Fenofibrate on Microalbuminuria December 2014 December 2016
NCT02409511 Unknown status Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy) January 2016 April 2018
NCT02462369 Unknown status Phase 4 Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients June 2015 October 2017
NCT02808845 Unknown status Microalbuminuria Predicting CIAKI After CAG December 2016
NCT03016910 Unknown status Coronary Artery Plaque Burden and Morphology in Type 2 Diabetes Mellitus. March 2016 September 2019
NCT03596840 Unknown status Community-based Microalbuminuria Screening in Patients With Hypertension August 1, 2018 December 31, 2020
NCT04025996 Unknown status REWARD: Using the REtina as a Window To Detect Cardiac microvasculAR Dysfunction In Diabetes Mellitus February 20, 2018 May 31, 2021
NCT05016440 Withdrawn N/A Lisinopril for Renal Protection in Postpartum Preeclamptic Women September 2015 September 1, 2015
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0012594